Insulin degludec: No hint of added benefit in children and adolescents
Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act ...
Jun 1, 2015
0
6